Myomo, Inc. Reports Second Quarter 2017 Results
CAMBRIDGE, Mass., August 14, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more.
Myomo, Inc. Obtains CE Mark Approval for MyoPro®
Myomo, Inc. Obtains CE Mark Approval for MyoPro® Enables Company to Start Providing Devices in Europe CAMBRIDGE, Mass., July 31, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis […]
Myomo Expands Management Team
Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis CAMBRIDGE, Mass., July 25, 2017 – Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with three new full-time positions in medical affairs, sales and marketing. The expansion marks the company’s accelerated commercialization of […]
Myomo, Inc. Introduces Center of Excellence Program
Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Cambridge, MA., July 12, 2017 – Myomo®, Inc. (NSYE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top […]
Myomo, Inc. Launches MyoPro® 2
Powered Arm Orthosis Features Interchangeable, Extended-life Rechargeable Batteries Myomo, Inc. (NSYE MKT: MYO) today announced the launch of its next-generation MyoPro® myoelectric arm orthosis (powered brace), the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury, […]
Myomo, Inc. Trades On The New York Stock Exchange MKT
Myomo, Inc. today announces that following the close of its initial public offering, its common shares will begin trading on the NYSE. Read press release.
Myomo, Inc. Completes Historic Initial Public Offering
First company to go public on the NYSE MKT under JOBS Act Regulation A+ Cambridge, MA., June 9, 2017 – Myomo, Inc. (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares […]
Myomo Launches IPO Via Jobs Act Regulation A+ with Sights Set on NYSE MKT Listing
Everyday Investors Can Now Buy Stock in Pioneering Wearable Medical Robotics Company Cambridge, Mass. (March 15, 2017) – Myomo, Inc., a commercial stage medical robotics Company, today announced a Regulation A+ initial public offering that allows any investor the opportunity to invest in the Company’s vision for expanded mobility for those suffering from neurological disorders and […]
Three Companies Receive 2017 Seed Funds to Develop Medical Devices for Children
The Philadelphia Pediatric Medical Device Consortium, based at CHOP, will fund Powered Orthotic Brace, Rapid Blood Delivery and Ear Reshaper. The Philadelphia Pediatric Medical Device Consortium (PPDC) has announced seed grants to three companies developing medical devices for children. Myomo is proud to be one of the top three picks. Read more.
Ottobock and Myomo Enter into Exclusive Global Distribution Agreement
Companies form sales partnership to offer myoelectric orthotic technology in select markets starting January 1, 2017 AUSTIN, Texas and CAMBRIDGE, Mass. (December 19, 2016) — Ottobock, a world market leader in technical orthopedics, and Myomo, Inc., a leading manufacturer of myoelectric orthotics, “Ottobock is committed to providing orthotic solutions to drive successful patient outcomes and meet […]